Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas.
Saenz-Ponce N, Pillay R, de Long LM, Kashyap T, Argueta C, Landesman Y, Hazar-Rethinam M, Boros S, Panizza B, Jacquemyn M, Daelemans D, Gannon OM, Saunders NA.
Saenz-Ponce N, et al. Among authors: hazar rethinam m.
Sci Transl Med. 2018 Jun 27;10(447):eaar7223. doi: 10.1126/scitranslmed.aar7223.
Sci Transl Med. 2018.
PMID: 29950445